A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood

NeuroToxicology

Volumn 44, Issue , 2014, Pages 121-131

  Yoshimasu, Kouichi ^a   Kiyohara, Chikako ^b   Takemura, Shigeki ^a   Nakai, Kunihiko ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ADHD; Autism; Mercury exposure; Meta analysis; Thimerosal

Indexed keywords

MERCURY; ORGANOMERCURY COMPOUND; THIOMERSAL;

ATTENTION DEFICIT DISORDER; AUTISM; CHILD; DEVELOPMENTAL DISORDER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HEAVY METAL POISONING; HEREDITY; HUMAN; INCIDENCE; META ANALYSIS; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; CHEMICALLY INDUCED; FEMALE; MALE; PREGNANCY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MERCURY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; THIMEROSAL; YOUNG ADULT;

EID: 84903737123     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2014.06.007     Document Type: Review

References (56)

1. Andrews N., Miller E., Grant A., Stowe J., Osborne V., Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114:584-591.
2. Aschner M., Ceccatelli S. Are neuropathological conditions relevant to ethylmercury exposure?. Neurotox Res 2010, 18:59-68.
3. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
4. Blanchard K.S., Palmer R.F., Stein Z. The value of ecologic studies: mercury concentration in ambient air and the risk of autism. Rev Environ Health 2011, 26:111-118.
5. Boucher O., Jacobson S.W., Plusquellec P., Dewailly E., Ayotte P., Dubois N.F., et al. Prenatal methylmercury, postnatal lead exposure, and evidence of attention deficit/hyperactivity disorder among Inuit children in Arctic Québec. Environ Health Perspect 2012, 120:1456-1461.
6. Bridges C.C., Zalups R.K. Transport of inorganic mercury and methylmercury in target tissues and organs. J Toxicol Environ Health Part B: Crit Rev 2010, 13:385-410.
7. Clarkson T.W., Vyas J.B., Ballatori N. Mechanisms of mercury disposition in the body. Am J Ind Med 2007, 50:757-764.
8. Clifton J.C. Mercury exposure and public health. Pediatr Clin North Am 2007, 54:237-269.
9. Cortese S. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): what every clinician should know. Eur J Paediatr Neurol 2012, 16:422-433.
10. Croen L.A., Matevia M., Yoshida C.K., Grether G.K. Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. Am J Obstet Gynecol 2008, 199:234.
11. Davidson P.W., Myers G.J., Weiss B. Mercury exposure and child developmental outcomes. Pediatrics 2004, 113:1023-1029.
12. Debes F., Jørgensen B.E., Weihe P., White R.F., Grandjean P. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006, 28:363-375.
13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Cont Clin Trials 1986, 7:177-188.
14. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
15. Franke B., Faraone S.V., Asherson P., Buitelaar J., Bau C.H., Ramos-Quiroga J.A., et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 2012, 17:960-987.
16. Geier M.R., Geier D.A. Neurodevelopmental disorders after thimerosal-containing vaccines: brief communication. Exp Biol 2003, 228:660-664.
17. Geier M.R., Geier D.A. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. Med Sci Monit 2005, 11:CR160-CR170.
18. Geier D.A., Geier M.R. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuroendocrinol Lett 2006, 27:401-413.
19. Geier D.A., Geier M.R. A prospective study of thimerosal-containing Rho (D)-immune globulin administration as a risk factor for autistic disorders. J Maternal Fetal Neonatal Med 2007, 20:385-390.
20. Geier D.A., Mumper E., Gladfelter B., Coleman L., Geier M.R. Neurodevelopmental disorders, maternal Rh-negativity, and Rho (D) immune globulins: a multi-center assessment. Neuroendocrinol Lett 2008, 29:272-280.
21. Geier D.A., Kern J.K., Geier M.R. The biological basis of autism spectrum disorders: understanding causation and treatment by clinical geneticists. Acta Neurobiol Exp 2010, 70:209-226.
22. Grizenko N., Shayan Y.R., Polotskaia A., Ter-Stepanian M., Joober R. Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci 2008, 33:10-16.
23. Grizenko N., Fortier M.E., Zadorozny C., Thakur G., Schmitz N., Duval R., et al. Maternal stress during pregnancy, ADHD symptomatology in children and genotype: gene-environment interaction. J Can Acad Child Adolesc Psychiatry 2012, 21:9-15.
24. Ha M., Kwon H.J., Lim M.H., Jee Y.K., Hong Y.C., Leem J.H., et al. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER). Neurotoxicology 2009, 30:31-36.
25. Heron J., Golding J. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004, 114:577-583.
26. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br Med J 2003, 327:557-560.
27. Hviid A., Stellfeld M., Wohlfahrt J., Melbye M. Association between thimerosal-containing vaccine and autism. J Am Med Assoc 2003, 290:1763-1766.
28. Jensen T.K., Grandjean P., Jørgensen B.E., White R.F., Debes F., Weihe P. Effects of breast feeding on neuropsychological development in a community with methylmercury exposure from seafood. J Expo Anal Environ Epidemiol 2005, 15:423-430.
29. Kalkbrenner A.E., Daniels J.L., Chen J.C., Poole C., Emch M., Morrissey J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 2010, 21:631-641.
30. Kim S., Arora M., Fernandez C., Landero J., Caruso J., Chen A. Lead, mercury, and cadmium exposure and attention deficit hyperactivity disorder in children. Environ Res 2013, 126:105-110.
31. Levav-Rabkin T., Melamed O., Clarke G., Farber M., Cryan J.F., Dinan T.G., et al. A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent. Neuropsychopharmacology 2010, 35:1138-1154.
32. Lewandowski T.A., Bartell S.M., Yager J.W., Levin L. An evaluation of surrogate chemical exposure measures and autism prevalence in Texas. J Toxicol Environ Health Part A 2009, 72:1592-1603.
33. Martin M.D., Woods J.S. The safety of dental amalgam in children. Exp Opin Drug Safety 2006, 5:773-781.
34. Mefford H.C., Batshaw M.L., Hoffman E.P. Genomics, intellectual disability, and autism. New Engl J Med 2012, 366:733-743.
35. Miles J.H., Takahashi T.N. Lack of association between Rh status Rh immune globulin in pregnancy and autism. Am J Med Genet Part A 2007, 143A:1397-1407.
36. Myers G.J., Thurston S.W., Pearson A.T., Davidson P.W., Cox C., Shamlaye C.F., et al. Postnatal exposure to methyl mercury from fish consumption: a review and new data from the Seychelles Child Development Study. Neurotoxicology 2009, 30:338-349.
37. Ng D.K., Chan C.H., Soo M.T., Lee R.S. Low-level chronic mercury exposure in children and adolescents: meta-analysis. Pediatr Int 2007, 49:80-87.
38. Owens S.E., Summar M.L., Ryckman K.K., Haines J.L., Reiss S., Summar S.R., et al. Lack of association between autism and four heavy metal regulatory genes. Neurotoxicology 2011, 32:769-775.
39. Palmer R.F., Blanchard S., Stein Z., Mandell D., Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006, 12:203-209.
40. Palmer R.F., Blanchard S., Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 2009, 15:18-24.
41. Price C.S., Thompson W.W., Goodson B., Weintraub E.S., Croen L.A., Hinrichsen V.L., et al. Prenatal and infant exposure to thimerosal from vaccine and immunoglobulins and risk of autism. Pediatrics 2010, 126:656-664.
42. Roberts A.L., Lyall K., Hart J.E., Laden F., Just A.C., Bobb J.F., et al. Perinatal air pollutant exposure and autism spectrum disorder in the children of Nurse's Health Study II participants. Environ Health Perspect 2013, 121:978-984.
43. Rosenberg J., Pennington B.F., Willcutt E.G., Olson R.K. Gene by environment interactions influencing reading disability and the inattentive symptom dimension of attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 2012, 53:243-251.
44. Sagiv S.K., Thurston S.W., Bellinger D.C., Amarasiriwardena C., Korrick S.A. Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med 2012, 8:1-9.
45. Scherer S.W., Dawson G. Risk factors for autism: translating genomic discoveries into diagnostics. Hum Genet 2011, 130:123-148.
46. Schultz S.T. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature. Acta Neurobiol Exp 2010, 70:187-195.
47. Stamova B., Green P.G., Tian Y., Hertz-Picciotto I., Pessah I.N., Hansen R., et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res 2011, 19:31-48.
48. Taurines R., Schwenck C., Westerwald E., Sachse M., Siniatchkin M., Freitag C. ADHD and autism: differential diagnosis or overlapping traits? A selective review. ADHD Atten Def Hyp Disord 2012, 4:115-139.
49. Thakur G.A., Sengupta S.M., Grizenko M., Schmitz N., Pagé V., Joober R. Maternal smoking during pregnancy and ADHD: a comprehensive clinical and neurocognitive characterization. Nicotine Tob Res 2012, 22. [Epub ahead of print].
50. Thapar A., Cooper M., Jefferies R., Stergiakouli E. What causes attention deficit hyperactivity disorder?. Arch Dis Child 2012, 97:260-265.
51. Torvik F.A., Rognmo K., Ask H., Røysamb E., Tambs K. Parental alcohol use and adolescent school adjustment in the general population: results from the HUNT study. BMC Public Health 2011, 11:706.
52. van Wijngaarden E., Myers G.J., Thurston S.W., Shamlaye C.F., Davidson P.W. Interpreting epidemiological evidence in the presence of multiple endpoints: an alternative analytic approach using the 9-year follow-up of the Seychelles Child Development Study. Int Arch Occup Environ Health 2009, 82:1031-1041.
53. Verstraeten T., Davis R.L., DeStefano F., Lieu T.A., Rhodes P.H., Black S.B., et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003, 112:1039-1048.
54. Watson G.E., Lynch M., Myers G.J., Shamlaye C.F., Thurston S.W., Zareba G., et al. Prenatal exposure to dental amalgam: evidence from the Seychelles Child Development Study main cohort. J Am Dent Assoc 2011, 142:1283-1294.
55. Whitehead A., Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trial. Stat Med 1991, 10:1665-1677.
56. Windham G.C., Zhang L., Gunier R., Croen L.A., Grether J.K. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay Area. Environ Health Perspect 2006, 114:1438-1444.